412 related articles for article (PubMed ID: 22001105)
1. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.
Budäus L; Bolla M; Bossi A; Cozzarini C; Crook J; Widmark A; Wiegel T
Eur Urol; 2012 Jan; 61(1):112-27. PubMed ID: 22001105
[TBL] [Abstract][Full Text] [Related]
2. Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review.
Le Guevelou J; Sargos P; Ferretti L; Supiot S; Pasquier D; Créhange G; Blanchard P; Hennequin C; Chapet O; Schick U; Baty M; Masson I; Ploussard G; De Crevoisier R; Latorzeff I
Eur Urol Oncol; 2024 Jun; 7(3):332-343. PubMed ID: 37640583
[TBL] [Abstract][Full Text] [Related]
3. Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review.
Neerhut T; Grills R; Lynch R; Preece PD; McLeod K
Urol Oncol; 2024 Jun; 42(6):165-174. PubMed ID: 38503591
[TBL] [Abstract][Full Text] [Related]
4. Safety of Radiation Therapy in Patients With Prostate Cancer and Inflammatory Bowel Disease: A Systematic Review.
Trotta M; Patel KR; Singh S; Verma V; Ryckman J
Pract Radiat Oncol; 2023; 13(5):454-465. PubMed ID: 37100389
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer.
Lilleby W; Kishan A; Geinitz H
World J Urol; 2024 Jan; 42(1):41. PubMed ID: 38244053
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review.
Bodofsky S; Freeman RH; Hong SS; Chundury A; Hathout L; Deek MP; Jabbour SK
J Gastrointest Oncol; 2022 Oct; 13(5):2565-2582. PubMed ID: 36388654
[TBL] [Abstract][Full Text] [Related]
8. Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review.
Thompson D; Bensley JG; Tempo J; Ehdaie B; Carlsson S; Eastham J; Bolton D; Perera M; Papa N
Eur Urol Oncol; 2023 Feb; 6(1):4-15. PubMed ID: 36156268
[TBL] [Abstract][Full Text] [Related]
9. Focal therapy for prostate cancer: rationale and treatment opportunities.
Kasivisvanathan V; Emberton M; Ahmed HU
Clin Oncol (R Coll Radiol); 2013 Aug; 25(8):461-73. PubMed ID: 23759249
[TBL] [Abstract][Full Text] [Related]
10. Assessing the Efficacy and Long-Term Outcomes of Surgical Intervention Versus Radiotherapy: A Comprehensive Systematic Review and Meta-Analysis of Prostate Cancer Treatment Modalities.
Waraich TA; Khalid SY; Kathia UM; Ali A; Qamar SSS; Yousuf A; Saleem RMU
Cureus; 2024 Apr; 16(4):e58842. PubMed ID: 38784314
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer invading rectal serosa and anal sphincter treated with definitive radiation therapy: Case report and review of the literature.
Lee MJ
J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102902
[TBL] [Abstract][Full Text] [Related]
12. Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology.
Hall WA; Kishan AU; Hall E; Nagar H; Vesprini D; Paulson E; Van der Heide UA; Lawton CAF; Kerkmeijer LGW; Tree AC
Front Oncol; 2022; 12():962897. PubMed ID: 36132128
[TBL] [Abstract][Full Text] [Related]
13. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.
Franco NR; Massi MC; Ieva F; Manzoni A; Paganoni AM; Zunino P; Veldeman L; Ost P; Fonteyne V; Talbot CJ; Rattay T; Webb A; Johnson K; Lambrecht M; Haustermans K; De Meerleer G; de Ruysscher D; Vanneste B; Van Limbergen E; Choudhury A; Elliott RM; Sperk E; Veldwijk MR; Herskind C; Avuzzi B; Noris Chiorda B; Valdagni R; Azria D; Farcy-Jacquet MP; Brengues M; Rosenstein BS; Stock RG; Vega A; Aguado-Barrera ME; Sosa-Fajardo P; Dunning AM; Fachal L; Kerns SL; Payne D; Chang-Claude J; Seibold P; West CML; Rancati T;
Radiother Oncol; 2021 Jun; 159():241-248. PubMed ID: 33838170
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Primer on Radiation Oncology for Non-Radiation Oncologists.
Beddok A; Lim R; Thariat J; Shih HA; El Fakhri G
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894273
[No Abstract] [Full Text] [Related]
15. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.
Heumann P; Aguado-Barrera ME; Avuzzi B; Azria D; Briers E; Bultijnck R; Choudhury A; De Ruysscher D; Farcy-Jacquet MP; Fonteyne V; Gómez Caamaño A; Helmbold I; Johnson K; Kerns SL; Lambrecht M; Lingard Z; Rancati T; Rosenstein BS; Sperk E; Paul Symonds R; Talbot C; Valdagni R; Vega A; Veldeman L; Ward T; Webb A; West CM; Chang-Claude J; Seibold P;
Radiother Oncol; 2023 Jan; 178():109426. PubMed ID: 36442608
[TBL] [Abstract][Full Text] [Related]
16. Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity.
Schlaak RA; SenthilKumar G; Boerma M; Bergom C
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32053873
[TBL] [Abstract][Full Text] [Related]
17. Long term clinical toxicity of radiation therapy in prostate cancer patients with Inflammatory Bowel Disease.
Gestaut MM; Swanson GP
Rep Pract Oncol Radiother; 2017; 22(1):77-82. PubMed ID: 27920612
[TBL] [Abstract][Full Text] [Related]
18. Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials.
Marcello M; Denham JW; Kennedy A; Haworth A; Steigler A; Greer PB; Holloway LC; Dowling JA; Jameson MG; Roach D; Joseph DJ; Gulliford SL; Dearnaley DP; Sydes MR; Hall E; Ebert MA
Front Oncol; 2020; 10():1174. PubMed ID: 32793485
[No Abstract] [Full Text] [Related]
19. The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.
Jackson A; Marks LB; Bentzen SM; Eisbruch A; Yorke ED; Ten Haken RK; Constine LS; Deasy JO
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3 Suppl):S155-60. PubMed ID: 20171512
[TBL] [Abstract][Full Text] [Related]
20. PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement.
Isabelle Choi J; Wojcieszynski A; Amos RA; Giap H; Apisarnthanarax S; Ashman JB; Anand A; Perles LA; Williamson T; Ramkumar S; Molitoris J; Simone CB; Chuong MD
Int J Part Ther; 2024 Mar; 11():100019. PubMed ID: 38757077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
